Standout Papers
- Acute and chronic graft-versus-host disease in dogs given hemopoietic grafts from DLA-nonidentical littermates. Two distinct syndromes. (1982)
- RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTING (1984)
- HUMAN T LYMPHOCYTE PHENOTYPES AFTER BONE MARROW TRANSPLANTATION T CELLS EXPRESSING IA-LIKE ANTIGEN (1983)
- In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance. (1980)
Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Identification of the haematopoietic stem cell niche and control of the niche size
2003 StandoutNature
Outcomes of Adults with Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
2013
Hallmarks of Cancer: The Next Generation
2011 Standout
Systematic Analysis of Reportedly Distinct Populations of Multipotent Bone Marrow-Derived Stem Cells Reveals a Lack of Distinction
2002
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
2010
Cell-Mediated Immunity to Varicella-Zoster Virus after Allogeneic Marrow Transplant
1980
Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids
1981
Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine
1985
Development of Resistance to Acyclovir during Chronic Infection with the Oka Vaccine Strain of Varicella‐Zoster Virus, in an Immunosuppressed Child
2003
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
1994
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Efficacy and Safety of Vaccination of Marrow Transplant Recipients with a Live Attenuated Measles, Mumps, and Rubella Vaccine
1989
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Pathways of T‐cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy
1997
The Participation of Mesenchymal Stem Cells in Tumor Stroma Formation and Their Application as Targeted-Gene Delivery Vehicles
2007
Immunological reconstitution following bone marrow transplantation
1997
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Immunogenicity of Haemophilus influenzae Type b Conjugate Vaccine in Allogeneic Bone Marrow Recipients
1992
Epigenetic regulation of aging stem cells
2011
Response to Tetanus Toxoid Immunization after Allogeneic Bone Marrow Transplantation
1990
Cytogenetics in acute leukemia
2003
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
2005
Wound repair and regeneration
2008 StandoutNature
Treatment of severe acute graft‐versus‐host disease with anti‐thymocyte globulin
2001
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Immunoregulatory function of mesenchymal stem cells
2006
Is chronic graft versus host disease an autoimmune disease?
1993
B Cells and Transplantation: An Educational Resource
2009
Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT)
2008
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy
1995
Safety and Immunogenicity of the Live Attenuated Varicella Vaccine Following T Replete or T Cell-Depleted Related and Unrelated Allogeneic Hematopoietic Cell Transplantation (alloHCT)
2011
Protein folding in the cell
1992 StandoutNature
Molecular and functional characterization of early human hematopoiesis
2012
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Stem cells, ageing and the quest for immortality
2006 StandoutNature
Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic Neoplasms
1989
Vaccines for Transplant Recipients
2001
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
2007
Stem Cells: Hype and Reality
2002
Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study
2009
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
The Hallmarks of Aging
2013 Standout
Immune modulation by mesenchymal stem cells
2006
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
2002
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Toward Regenerative Medicine
2001
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
2015
Extrathymic positive selection of αβ T-cell precursors in nude mice
1992 StandoutNatureNobel
Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood
2007
Changes in thymic function with age and during the treatment of HIV infection
1998 StandoutNature
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation
1995
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy
1986 StandoutNobel
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
1985
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants
2006
Cytomegalovirus Infection and Specific Cell-Mediated Immunity after Marrow Transplant
1980
Adipose Tissue‐Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft‐Versus‐Host Disease
2006
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia
1985
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Marrow Transplantation in Thirty "Untransfused" Patients with Severe Aplastic Anemia
1980 StandoutNobel
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose
1993
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Increased in vitro B-cell IgG secretion during acute graft-versus-host disease and infection. Observations in 50 human marrow transplant recipients
1980
Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation
2007
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients
1982
Lymphocyte Homing and Homeostasis
1996 StandoutScience
Pneumococcal Infections After Human Bone-Marrow Transplantation
1979
Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' Experience
1982 StandoutNobel
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
2005
Predictive Factors in Chronic Graft-Versus-Host Disease in Patients with Aplastic Anemia Treated by Marrow Transplantation from HLA-Identical Siblings
1983
Hematopoietic Stem and Progenitor Cells: Clinical and Preclinical Regeneration of the Hematolymphoid System
2002
Transfer and Persistence of Viral Antibody-Producing Cells in Bone Marrow Transplantation
1984
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
The pathophysiology and treatment of graft-versus-host disease
1983
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
2003
Immunological analysis of the skin in graft versus host disease.
1982
Marrow Transplantation for Thalassemiaa
1985 StandoutNobel
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting
1983
Streptococcus pneumoniae Infections in 47 Hematopoietic Stem Cell Transplantation Recipients
2007
Bone Marrow Contains Virus-Specific Cytotoxic T Lymphocytes
1997
Partially Mismatched Related-Donor Bone Marrow Transplantation for Pediatric Patients With Acute Leukemia: Younger Donors and Absence of Peripheral Blasts Improve Outcome
2000
Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants
2000
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
The detection of specific antibody formation to recall antigens after human bone marrow transplantation
1986
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patients
1980
Adenovirus Infections in Patients Undergoing Bone-Marrow Transplantation
1985
Protective Environment for Marrow Transplant Recipients
1978
The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients
1986
Specific suppressor cells in graft–host tolerance of HLA-identical marrow transplantation
1981 StandoutNatureNobel
Pneumococcal Vaccination of Recipients of Bone Marrow Transplants
1983
Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical Siblings
1983
Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience
1985 StandoutNobel
TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW
1986
Aplastic Anemia
1982 StandoutNobel
Epstein‐Barr virus‐related serology in marrow transplant recipients
1980
Antileukemic Effect of Chronic Graft-versus-Host Disease
1981
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens.
1986 StandoutNobel
Chronic graft versus host disease: A syndrome of disordered immunity
1979
Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia
1983 StandoutNobel
Subsets of Patients with Aplastic Anemia Identified by Flow Microfluorometry
1985 StandoutNobel
Designed transfer of specific immune responses with bone marrow transplantation.
1986
Titers of Antibody to Pneumococci in Allogeneic Bone Marrow Transplant Recipients Before and After Vaccination with Pneumococcal Vaccine
1986
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants
1984 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
Antithymocyte Globulin Treatment in Patients with Aplastic Anemia
1983
Intermediate-Dose Methotrexate and Intravenous 6-Mercaptopurine Chemotherapy for Children With Acute Lymphoblastic Leukemia Who Did Not Respond to Initial Induction Therapy
2002
Human mesenchymal stem cells modulate B-cell functions
2005
Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.
1985
Progress and Potential for Regenerative Medicine
2006
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation
1994
Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting
1983
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts
1989
Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction
1993
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny
1993
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
The Biology and Detection of Immune Complexes
1980
EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE
1984
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
1997
Chronic graft-versus-host syndrome in man
1980 Standout
Marrow Transplantation for Treatment of Aplastic Anaemia
1978 StandoutNobel
Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant
1980
Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation
1996
Complementary DNA for human T-cell cyclophilin.
1987
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft- versus-host disease
1985
Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. One gene codes for both the cytosolic and mitochondrial forms.
1988
Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation
1982 StandoutNobel
Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
2003
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Allogeneic Bone‐Marrow Transplantation
1983
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
2006
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse
1994
Lymphocytic Bronchitis Associated with Graft-versus-Host Disease in Recipients of Bone-Marrow Transplants
1978
Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation
1990
Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
1997
Works of K Atkinson being referenced
Deposition of IgM and Complement at the Dermoepidermal Junction in Acute and Chronic Cutaneous Graft-Vs-Host Disease in Man
1978
GM‐CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes*
1991
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma
2001
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer
2000
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study
2004
Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients
2005
Cyclosporin-A abrogates transfusion-induced sensitization and prevents marrow graft rejection in DLA-identical canine littermates
1982
Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty.
1987
Marrow Graft Studies in Dogs
1980
Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission.
1995
Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
1987
Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation
1983
Bone marrow transplantation
1992
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
1992
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
1992
Erythroid colony stimulating and inhibiting cells in peripheral blood of transfused dogs: separation of function by velocity sedimentation
1979
Infection in bone marrow transplantation
1983
Analysis of late infections in 89 long-term survivors of bone marrow transplantation
1979
RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTING
1984 StandoutNobel
Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes
1983
T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets
1982
Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors
1978
In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance.
1980 StandoutNobel
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.
1993
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]
1993
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
1992
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]
1993
VARICELLA-ZOSTER VIRUS INFECTION AFTER MARROW TRANSPLANTATION FOR APLASTIC ANEMIA OR LEUKEMIA
1980
CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
1984
Low serum thymic hormone levels in patients with chronic graft-versus- host disease
1982
Deposition of IgM and Complement at the Dermoepidermal Junction in Acute and Chronic Cutaneous Graft-Vs-Host Disease in Man
1978
Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2
1991
Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma
1998
Cyclosporin-A: effect on marrow engraftment and graft-versus-host disease in dogs.
1981
THYMUS TRANSPLANTATION AFTER ALLOGENEIC BONE MARROW GRAFT TO PREVENT CHRONIC GRAFT-VERSUS-HOST DISEASE IN HUMANS
1982
Second HLA-identical sibling transplants for leukemia recurrence.
1992
Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment
1981
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma
2000
Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease
1982
Apparent cure of rheumatoid arthritis by bone marrow transplantation.
1993
Female marrow donors increase the risk of acute graft‐versus‐host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum
1986
CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION
1982
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression
1981
Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells
1979